{"source_url": "https://www.yumab.com", "url": "https://www.yumab.com/enleofen-enters-joint-development-with-boehringer-ingelheim/", "title": "YUMAB partner Enleofen enters joint development Boehringer Ingelheim", "top_image": "https://www.yumab.com/wp-content/uploads/2019/07/IL-11_925x500-1.jpg", "meta_img": "https://www.yumab.com/wp-content/uploads/2019/07/IL-11_925x500-1.jpg", "images": ["https://www.yumab.com/wp-content/uploads/2018/10/fax.png", "https://www.yumab.com/wp-content/uploads/2020/05/pegs-virtual-80x80.jpg", "https://www.yumab.com/wp-content/uploads/2019/07/IL-11_925x500-1.jpg", "https://www.yumab.com/wp-content/uploads/2018/08/YUMAB-Logo-e1457524105418.png", "https://www.yumab.com/wp-content/uploads/2020/03/Team-YUMAB-mit-Hund-80x80.jpg", "https://www.yumab.com/wp-content/uploads/2018/10/phone.png"], "movies": [], "text": "We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.\n\nClick on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.", "keywords": [], "meta_keywords": [""], "tags": [], "authors": [], "publish_date": "Wed Jan 22 09:25:50 2020", "summary": "", "article_html": "", "meta_description": "Enleofen announced collaboration with Boehringer Ingelheim to develop novel anti-IL-11 therapies for a range of fibrotic diseases. YUMAB has been cooperating with Enleofen\u00b4s founders \u2013 among other partners \u2013 to generate an extensive anti-IL-11 platform of fully human antibodies as basis for this next step towards clinical development.", "meta_lang": "en", "meta_favicon": "https://www.yumab.com/wp-content/uploads/2019/04/yumab-favicon.png", "meta_data": {"viewport": "width=device-width, initial-scale=1, maximum-scale=1", "description": "Enleofen announced collaboration with Boehringer Ingelheim to develop novel anti-IL-11 therapies for a range of fibrotic diseases. YUMAB has been cooperating with Enleofen\u00b4s founders \u2013 among other partners \u2013 to generate an extensive anti-IL-11 platform of fully human antibodies as basis for this next step towards clinical development.", "robots": "noindex,follow", "og": {"locale": "en_GB", "type": "article", "title": "YUMAB partner Enleofen enters joint development Boehringer Ingelheim", "description": "Enleofen announced collaboration with Boehringer Ingelheim to develop novel anti-IL-11 therapies for a range of fibrotic diseases. YUMAB has been cooperating with Enleofen\u00b4s founders \u2013 among other partners \u2013 to generate an extensive anti-IL-11 platform of fully human antibodies as basis for this next step towards clinical development.", "url": "https://www.yumab.com/enleofen-enters-joint-development-with-boehringer-ingelheim/", "site_name": "YUMAB GmbH", "updated_time": "2020-01-22T15:42:38+00:00", "image": {"identifier": "https://www.yumab.com/wp-content/uploads/2019/07/IL-11_925x500-1.jpg", "secure_url": "https://www.yumab.com/wp-content/uploads/2019/07/IL-11_925x500-1.jpg", "width": 1640, "height": 887}}, "article": {"section": "News", "published_time": "2020-01-22T09:25:50+00:00", "modified_time": "2020-01-22T15:42:38+00:00"}, "twitter": {"card": "summary_large_image", "description": "Enleofen announced collaboration with Boehringer Ingelheim to develop novel anti-IL-11 therapies for a range of fibrotic diseases. YUMAB has been cooperating with Enleofen\u00b4s founders \u2013 among other partners \u2013 to generate an extensive anti-IL-11 platform of fully human antibodies as basis for this next step towards clinical development.", "title": "YUMAB partner Enleofen enters joint development Boehringer Ingelheim", "image": "https://www.yumab.com/wp-content/uploads/2019/07/IL-11_925x500-1.jpg"}, "generator": "WordPress 5.3.3"}, "canonical_link": "https://www.yumab.com/enleofen-enters-joint-development-with-boehringer-ingelheim/"}